4.4 Article

Plasma glucagon-like peptide-1 responses to ingestion of protein with increasing doses of milk minerals rich in calcium

Journal

BRITISH JOURNAL OF NUTRITION
Volume 128, Issue 1, Pages 55-63

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S000711452100297X

Keywords

Calcium; Protein; GLP-1; Appetite; Energy intake

Funding

  1. Arla Foods Ingredients
  2. University of Bath
  3. BBSRC
  4. MRC
  5. British Heart Foundation
  6. Lucozade Ribena Suntory
  7. Arla Foods Ingredient
  8. Kenniscentrum Suiker and Voeding
  9. Rare Disease Foundation
  10. EU Hydration Institute
  11. GlaxoSmithKline
  12. Nestle
  13. ARLA Foods
  14. Kennis Centrum Suiker

Ask authors/readers for more resources

This study aimed to assess the impact of different calcium doses ingested alongside whey protein hydrolysate on GLP-1 concentrations in individuals with overweight/obesity. The results showed that co-ingestion of whey protein hydrolysate with Capolac(R) did not potentiate GLP-1 release compared to whey protein hydrolysate alone.
A high dose of whey protein hydrolysate fed with milk minerals rich in calcium (Capolac(R)) results in enhanced glucagon-like peptide-1 (GLP-1) concentrations in lean individuals; however, the effect of different calcium doses ingested alongside protein is unknown. The present study assessed the dose response of calcium fed alongside 25 g whey protein hydrolysate on GLP-1 concentrations in individuals with overweight/obesity. Eighteen adults (mean +/- sd: 8M/10F, 34 +/- 18 years, 28 center dot 2 +/- 2 center dot 9 kgm(-2)) completed four trials in a randomised, double-blind, crossover design. Participants consumed test solutions consisting of 25 g whey protein hydrolysate (CON), supplemented with 3179 mg (LOW), 6363 mg (MED) or 9547 mg (HIGH) Capolac(R) on different occasions, separated by at least 48 h. The calcium content of test solutions equated to 65, 892, 1719 and 2547 mg, respectively. Arterialised-venous blood was sampled over 180 min to determine plasma concentrations of GLP-1(TOTAL), GLP-1(7-36amide), insulin, glucose, NEFA, and serum concentrations of calcium and albumin. Ad libitum energy intake was measured at 180 min. Time-averaged incremental AUC (iAUC) for GLP-1(TOTAL) (pmol center dot l(-1)center dot min(-1)) did not differ between CON (23 +/- 4), LOW (25 +/- 6), MED (24 +/- 5) and HIGH (24 +/- 6). Energy intake (kcal) did not differ between CON (940 +/- 387), LOW (884 +/- 345), MED (920 +/- 334) and HIGH (973 +/- 390). Co-ingestion of whey protein hydrolysate with Capolac(R) does not potentiate GLP-1 release in comparison with whey protein hydrolysate alone. The study was registered at clinical trials (NCT03819972).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available